Fortis Healthcare Limited

INR 1,770

ovember 10, 2023 Fortis Healthcare announces Q2 FY24 Financial Results Consolidated revenues at INR 1,770 Crs, up 10.1%; Operating EBITDA at INR 330 Crs, 18.6% margin Hospital Business Q2 FY24 revenues u

rs,

2023 Fortis Healthcare announces Q2 FY24 Financial Results Consolidated revenues at INR 1,770 Crs, up 10.1%; Operating EBITDA at INR 330 Crs, 18.6% margin Hospital Business Q2 FY24 revenues up 12%

10.1%

Fortis Healthcare announces Q2 FY24 Financial Results Consolidated revenues at INR 1,770 Crs, up 10.1%; Operating EBITDA at INR 330 Crs, 18.6% margin Hospital Business Q2 FY24 revenues up 12% to INR

INR 330

Q2 FY24 Financial Results Consolidated revenues at INR 1,770 Crs, up 10.1%; Operating EBITDA at INR 330 Crs, 18.6% margin Hospital Business Q2 FY24 revenues up 12% to INR 1,453 Crs, Operating EBITDA at

18.6%

ncial Results Consolidated revenues at INR 1,770 Crs, up 10.1%; Operating EBITDA at INR 330 Crs, 18.6% margin Hospital Business Q2 FY24 revenues up 12% to INR 1,453 Crs, Operating EBITDA at INR 268 C

12%

s, up 10.1%; Operating EBITDA at INR 330 Crs, 18.6% margin Hospital Business Q2 FY24 revenues up 12% to INR 1,453 Crs, Operating EBITDA at INR 268 Crs, 18.4% margin Hospital business ARPOB increase

INR 1,453

0.1%; Operating EBITDA at INR 330 Crs, 18.6% margin Hospital Business Q2 FY24 revenues up 12% to INR 1,453 Crs, Operating EBITDA at INR 268 Crs, 18.4% margin Hospital business ARPOB increases 11.8% to INR

INR 268

rs, 18.6% margin Hospital Business Q2 FY24 revenues up 12% to INR 1,453 Crs, Operating EBITDA at INR 268 Crs, 18.4% margin Hospital business ARPOB increases 11.8% to INR 2.21 Crs Agilus Diagnostics fil

18.4%

gin Hospital Business Q2 FY24 revenues up 12% to INR 1,453 Crs, Operating EBITDA at INR 268 Crs, 18.4% margin Hospital business ARPOB increases 11.8% to INR 2.21 Crs Agilus Diagnostics files DRHP fo

11.8%

o INR 1,453 Crs, Operating EBITDA at INR 268 Crs, 18.4% margin Hospital business ARPOB increases 11.8% to INR 2.21 Crs Agilus Diagnostics files DRHP for a proposed IPO Financial Snapshot Consolida

INR 2.21

53 Crs, Operating EBITDA at INR 268 Crs, 18.4% margin Hospital business ARPOB increases 11.8% to INR 2.21 Crs Agilus Diagnostics files DRHP for a proposed IPO Financial Snapshot Consolidated (INR Crs)

23 %

gnostics files DRHP for a proposed IPO Financial Snapshot Consolidated (INR Crs) Q2FY24 Q2FY23 % Change YoY H1FY24 H1FY23 % Change YoY Revenue Operating EBITDA 1,770 330 1,607

“By attending or assessing this presentation you acknowledge that you will be solely responsible for your own assessment of the market and the market position of the Company and that you will conduct your own analysis and be solely responsible for forming your own view of the potential future performance of the business of the Company.”

Cash

2

For further details please contact

1

For further details please contact

Anurag Kalra Investor Relations +91-9810109253 Fortis Healthcare Limited Ajey Maharaj Corporate Communication +91-9871798573 Fortis Healthcare Limited 5/5 FORTIS HEALTHCARE LIMITED EARNINGS PRESENTATION – Q2 FY24 and H1 FY24 November 10, 2023 DISCLAIMER This presentation may not be copied, published, distributed or transmitted. The presentation has been prepared solely by the company. Any reference in this presentation to “Fortis Healthcare Limited” shall mean, collectively, the Company and its subsidiaries. This presentation has been prepared for informational purposes only. This presentation does not constitute a prospectus, offering circular or offering memorandum and is not an offer or invitation to buy or sell any securities, nor shall part, or all, of this presentation form the basis of, or be relied on in connection with, any contract or investment decision in relation to any securities. Furthermore, this presentation is not and should not be construed as an offer or a solicitat

Cash

Domestic, 36.0% Pvt Corps, 0.7% Govt & PSUs, 9.6% International , 8.0% CGHS, 3.3% ECHS, 6.2% Pvt Corps, 0.9% Govt & PSUs, 8.9% CGHS, 3.9% ECHS, 6.9% International , 8.3% HOSPITAL BUSINESS PERFORMANCE – Q2FY24 All the key healthcare facilities continue to witness an upward momentum in revenues 221 190 172 145 Revenue Q2FY23 Q2FY24 131 122 125 107 124 104 103 108 103 108 78 65 55 61 46 52 FMRI Mohali BG Road Shalimar Bagh Noida FEHI Mulund Anandpur Jaipur Faridabad 221 203 166 172 Revenue Q1FY24 Q2FY24 131 118 125 115 117 124 106 108 108 97 78 67 61 61 47 52 FMRI Mohali BG Road Shalimar Bagh Noida FEHI Mulund Anandpur Jaipur Faridabad All figures in INR Cr. HOSPITAL MARGIN MATRIX Margin improvement was witnessed across the board with multiple healthcare facilities moving up in the margin matrix * 4 2 Y F 2 Q 4 2 Y F 1 Q EBITDA No. of Facilities Revenue Contribution Operational Beds ARPOB (INR Cr) Occupancy 20% - 25% 15% - 20% 10% - 15% <10% 9 5 1 7 62.6% 16.7% 2.8% 17.1% 2,210 720 119 95